A

Asceneuron

0 followers

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Employees

11-50

Links


Org chart

Barbara Angehrn Pavik's profile picture
Barbara Angehrn Pavik
Chief Executive Officer
Profile photo

Barbara Angehrn Pavik

Collapse
Sandra Millet
Head Of Operations
Matthew Foy's profile picture
Matthew Foy
Investor
Eric Yuen's profile picture
Eric Yuen
Scientific Advisory Board Member
Andrin Cerletti's profile picture
Andrin Cerletti
Head Of Business Development
Abbas Hussain's profile picture
Henrijette Richter's profile picture
Henrijette Richter
Board Member
Ruhi Ahmed
SVP & Head of Regulatory Affairs
Bruno Permanne
Senior Director & Head of Preclinical Development
Colin Kahrs
Head of Intellectual Property

Board & advisors

Hakan Goker
Director
Eric Yuen
Director
Raymond G. Hill
Scientific Advisor
Christian Haass
Scientific Advisor
Adam Boxer
Scientific Advisor
Günter U. Höglinger
Scientific Advisor

Offices